Skip to main content

Newsletter block in header



  • English
  • Kiswahili

You are here



In Iran, Médecins Sans Frontières runs programmes to assist drug users, sex workers, refugees, homeless people and other vulnerable groups who face barriers when seeking healthcare.  

Key medical figures:

  • 29,900 outpatient consultations
  • 3,750 individual mental health consultations
  • 82 people treated for hepatitis C

Drug addiction is a particular public concern in Iran, with the number of drug users having doubled over the last six years to nearly three million (3.5 per cent of the population).  They, and other vulnerable groups such as sex workers, homeless people and the Ghorbati ethnic minority, suffer from stigma and exclusion in Iran, which limits their access to medical care. In 2018, this was further restricted by a financial crisis that crippled the health system. 

Our teams worked in south Tehran throughout the year, providing treatment for a range of communicable diseases to which marginalised communities are particularly exposed, including hepatitis B and C, HIV, tuberculosis (TB) and syphilis. We saw a large increase in the number of patients enrolling for hepatitis C treatment, an 82 per cent increase on 2017.

We also ran sexual and reproductive healthcare services, comprising gynaecology and obstetrics, ante- and postnatal care, and consultations for victims of sexual violence, as well as psychosocial support and counselling. A mobile clinic specifically for women was set up in the city.

In addition, we opened a new programme for refugees and the local community in Mashhad, near the Afghan border, where a significant number of the estimated two million Afghans in Iran live. Our teams there offer a similar range of services as in South Teheran: through fixed and mobile clinics, we treat hepatitis C and operate a referral system for patients needing treatment for HIV and/or TB.

COVID-19 Coronavirus

Most of the world's countries have reported cases of coronavirus disease COVID-19 and MSF teams in over 70 countries are now racing to respond to the pandemic.  

Find out more